Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)

Pilar Escribano Subias, Murali M. Chakinala, Kelly M. Chin, Eva-Maria Didden, Gurinderpal Doad, Harrison W. Farber, Sean Gaine, Anna R. Hemnes, Kristin B. Highland, Tobias J. Lange, Vallerie McLaughlin, Audrey Muller, Mohammad Rahman, Tatiana Remeňová, Stefan Söderberg, Apoorva Venkatesh, Nick H. Kim

Open source

DOI: 10.1007/s40801-025-00536-4
Published: 2026-01-12
Container: Drugs - Real World Outcomes
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40801-025-00536-4,
  title = {Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)},
  author = {Pilar Escribano Subias and Murali M. Chakinala and Kelly M. Chin and Eva-Maria Didden and Gurinderpal Doad and Harrison W. Farber and Sean Gaine and Anna R. Hemnes and Kristin B. Highland and Tobias J. Lange and Vallerie McLaughlin and Audrey Muller and Mohammad Rahman and Tatiana Remeňová and Stefan Söderberg and Apoorva Venkatesh and Nick H. Kim},
  year = {2026},
  journal = {Drugs - Real World Outcomes},
  doi = {10.1007/s40801-025-00536-4},
  url = {https://doi.org/10.1007/s40801-025-00536-4}
}

RIS

TY  - JOUR
TI  - Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)
AU  - Pilar Escribano Subias
AU  - Murali M. Chakinala
AU  - Kelly M. Chin
AU  - Eva-Maria Didden
AU  - Gurinderpal Doad
AU  - Harrison W. Farber
AU  - Sean Gaine
AU  - Anna R. Hemnes
AU  - Kristin B. Highland
AU  - Tobias J. Lange
AU  - Vallerie McLaughlin
AU  - Audrey Muller
AU  - Mohammad Rahman
AU  - Tatiana Remeňová
AU  - Stefan Söderberg
AU  - Apoorva Venkatesh
AU  - Nick H. Kim
PY  - 2026
JO  - Drugs - Real World Outcomes
DO  - 10.1007/s40801-025-00536-4
UR  - https://doi.org/10.1007/s40801-025-00536-4
ER  -

APA

Subias, P. E., Chakinala, M. M., Chin, K. M., Didden, E., Doad, G., Farber, H. W., Gaine, S., Hemnes, A. R., Highland, K. B., Lange, T. J., McLaughlin, V., Muller, A., Rahman, M., Remeňová, T., Söderberg, S., Venkatesh, A., & Kim, N. H. (2026). Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies). Drugs - Real World Outcomes. https://doi.org/10.1007/s40801-025-00536-4

Source records

crossref · retrieved 2026-09-27T03:42:17.047Z